CT ATLANTIC
CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies – HD-MABs™ as novel therapeutics for the treatment of cancer. CT Atlantic is a spin-off of the University of Zurich (Zurich, Switzerland) and the Ludwig Institute for Cancer Research (LICR) (Zurich, Switzerland and New York, USA) and has a strong focus on clinical research and applications in the field of oncology. It was founded by Prof. Alexander Knuth, Chairman of the ... Department of Clinical Oncology at the University of Zurich and one of the pioneers in cancer immunotherapy. He was previously Professor for Oncology at the Klinikum Nordwest (Frankfurt, Germany) and University of Frankfurt, Germany. Prior to this he led the clinical trials and research activities in the Ludwig Institute for Cancer Research, New York and its affiliate in the Krankenhaus Nordwest. The Company has entered into worldwide exclusive licensing agreements and performs collaborative research with both the University of Zurich and the LICR. In addition, it has built a network of clinicians and clinical institutions that are closely allied with the Ludwig Institute for Cancer Research, the University of Zurich and Krankenhaus Nordwest (Frankfurt, Germany). The company is currently based in Zurich-Schlieren, Switzerland.
CT ATLANTIC
Social Links:
Industry:
Apps Biotechnology
Founded:
2008-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.ct-atlantic.com
Total Employee:
1+
Status:
Closed
Contact:
+41 44 731 94 00
Email Addresses:
[email protected]
Total Funding:
8.97 M USD
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Founder
Investors List
HS LifeSciences
HS LifeSciences investment in Series A - CT Atlantic
More informations about "CT Atlantic"
CT Atlantic Company Profile: Valuation, Funding & Investors
Jan 12, 2009 CT Atlantic General Information Description. Provider of drugs designed to provide treatment of cancer. The company's drugs are use to treat cancer using antibodies derived …See details»
CT Atlantic AG - VentureRadar
" CT Atlantic AG is a Swiss biotech company focusing on the research and development of novel, human-derived antibodies for the treatment of cancer. Through the selection of the correct …See details»
ct atlantic Ltd. - startup.ch
Ct atlantic Ltd.: CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies – HD-MABs™ as novel therapeutics for …See details»
CT Atlantic - Funding, Financials, Valuation & Investors - Crunchbase
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer. Search Crunchbase. ... How much funding has this …See details»
CT Atlantic - Crunchbase
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer. Search Crunchbase. Start Free Trial . Chrome …See details»
CT Atlantic | Company | RadialReport
CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies – HD-MABs™ as novel therapeutics for the treatment of …See details»
CT Atlantic | EquityNet
CT Atlantic AG is a biotech company focused on the identification and development of human-derived monoclonal antibodies HD-MABs as novel therapeutics for the treatment of cancer. …See details»
CT Atlantic - Products, Competitors, Financials, Employees ...
CT Atlantic is an early stage company focused on the identification and development of human oncology. Use the CB Insights Platform to explore CT Atlantic's full profile. CT Atlantic - …See details»
CT Atlantic AG - BioCentury Company Profiles - BCIQ
CT Atlantic AG - BioCentury Company Profiles for the biopharma industrySee details»
CT Atlantic - Company Profile - Tracxn
Oct 19, 2024 CT Atlantic - Cancer therapeutics using humanized monoclonal antibodies. This company is not active anymore. Raised a total funding of $8.97M over 1 round from 1 investor. …See details»
Edward Stuart - Co-Founder & CEO @ CT Atlantic - Crunchbase
Edward Stuart was the original founding CEO of CT Atlantic and brings significant experience in business development for biotechnology start-ups. Stuart is a co-founder of HS LifeSciences …See details»
Research programme: CT antigen antibodies - CT Atlantic
CT Atlantic is developing patient-derived specific antibodies against CT antigens for the treatment of cancer. The company is using its proprietary BCDTech™See details»
CT Atlantic AG - VentureRadar
CT Atlantic AG is a Swiss biotech company focusing on the research and development of novel, human-derived antibodies for the treatment of cancer. Through the selection of the correct …See details»
Atlantic News | Local Breaking | CTV News Atlantic
Find breaking Atlantic & COVID-19 news, live coverage, weather, traffic, in-depth reporting, sports, local events and video. ... A nonprofit organization seeks to make beds for kids in the …See details»
Full article: Post-Fordism and the Transformation of Transatlantic ...
Nov 9, 2021 While it recognizes that national divergences remain, the paper argues the form and function of trans-Atlantic CT organization is best understood through post-Fordism. It proceeds …See details»
CT Atlantic - Contacts, Employees, Board Members, Advisors
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer. ... Products. Resources. Pricing. Resources. Log In. …See details»
Veteran Journalist Todd Battis Named Chief Anchor for CTV News …
Dec 16, 2021 Battis will helm CTV Atlantic’s flagship program CTV NEWS AT 6, the most-watched newscast in the Maritimes, beginning Monday, January 31, 2022. With decades of …See details»
News at 5 | News & Current Affairs | CTV Atlantic - CTV News …
CTV News at 5 is the Maritimes' most popular news and current affairs program, consistently drawing more than 210,000 viewers from Nova Scotia, New Brunswick and Prince Edward Island.See details»
CT Atlantic - Tech Stack, Apps, Patents & Trademarks - Crunchbase
CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer.See details»